Rapport Therapeutics Files Q1 2025 10-Q
Ticker: RAPP · Form: 10-Q · Filed: May 8, 2025 · CIK: 2012593
| Field | Detail |
|---|---|
| Company | Rapport Therapeutics, Inc. (RAPP) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceutical
TL;DR
Rapport Therapeutics Q1 2025 10-Q filed. Financials updated.
AI Summary
Rapport Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported its financial position and operational activities. Key financial data points and disclosures related to its business operations and strategic initiatives are detailed within the filing.
Why It Matters
This filing provides investors with an update on Rapport Therapeutics' financial health and operational progress for the first quarter of 2025, crucial for understanding the company's trajectory.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Rapport Therapeutics faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
- 2025-01-01 — Start of R&D Expense Period (Marks the beginning of the period for which Research and Development Expenses are reported.)
- 2024-12-31 — Previous Year End Date (Provides a comparative point from the end of the prior fiscal year.)
Key Players & Entities
- Rapport Therapeutics, Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of reporting period
- 0000950170-25-066393 (other) — Accession Number
- 001-42121 (other) — SEC File Number
- Boston, MA (location) — Company Headquarters
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20250331, indicating the period ending March 31, 2025.
What is Rapport Therapeutics, Inc.'s SEC File Number?
Rapport Therapeutics, Inc.'s SEC File Number is 001-42121.
Where is Rapport Therapeutics, Inc. headquartered?
Rapport Therapeutics, Inc. is headquartered in Boston, MA, with its business and mailing address listed as 1325 BOYLSTON STREET, SUITE 401, BOSTON, MA 02215.
What is the SIC code for Rapport Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Rapport Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
When was this 10-Q filing submitted?
This 10-Q filing was submitted on 20250508.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding Rapport Therapeutics, Inc. (RAPP).